Pancreatic Cancer Research

ResearcherSun Yat-sen UniversityActive in the last 2 years

Jinmao Zou

Matched on ORCID iD 0000-0002-5461-6818; OpenAlex author ID A5114147601. Sources: OpenAlex.

Their work

Papers
12
Trials
0
Grants
0
Labs led
0
Collaborators
29
Papers, trials and grants by year

2020: 2 papers · 2021: 1 paper · 2022: 2 papers · 2023: 2 papers · 2024: 4 papers · 2025: 1 paper

Papers 12

  1. Correction: Nanoparticles modified by triple single chain antibodies for MRI examination and targeted therapy in pancreatic cancer. Co-author DOI 10.1039/d5nr90172c↗
  2. Extracellular vesicle-packaged lncRNA from cancer-associated fibroblasts promotes immune evasion by downregulating HLA-A in pancreatic cancer. Co-author DOI 10.1002/jev2.12484↗
  3. Tumor-associated macrophages drive glycolysis through the IL-8/STAT3/GLUT3 signaling pathway in pancreatic cancer progression. Co-author DOI 10.1016/j.canlet.2024.216784↗
  4. Glycolysis and tumor progression promoted by the m6A writer VIRMA via m6A-dependent upregulation of STRA6 in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.canlet.2024.216840↗
  5. Low-dose arsenic trioxide inhibits pancreatic stellate cell activation via LOXL3 expression to enhance immunotherapy in pancreatic cancer. Co-author DOI 10.1038/s41416-024-02880-8↗
  6. Glutamate from nerve cells promotes perineural invasion in pancreatic cancer by regulating tumor glycolysis through HK2 mRNA-m6A modification. Co-author DOI 10.1016/j.phrs.2022.106555↗
  7. Development and validation of a radiomics model of magnetic resonance for predicting liver metastasis in resectable pancreatic ductal adenocarcinoma patients. Co-author DOI 10.1186/s13014-023-02273-w↗
  8. TIMP1 derived from pancreatic cancer cells stimulates Schwann cells and promotes the occurrence of perineural invasion. Co-author DOI 10.1016/j.canlet.2022.215863↗
  9. GLUT1 Regulates the Tumor Immune Microenvironment and Promotes Tumor Metastasis in Pancreatic Adenocarcinoma via ncRNA-mediated Network. Co-author DOI 10.7150/jca.72161↗
  10. TIMP1 down-regulation enhances gemcitabine sensitivity and reverses chemoresistance in pancreatic cancer. Co-author DOI 10.1016/j.bcp.2020.114085↗
  11. Development and validation of a novel nomogram for pretreatment prediction of liver metastasis in pancreatic cancer. Co-author DOI 10.1002/cam4.2930↗
  12. Nanoparticles modified by triple single chain antibodies for MRI examination and targeted therapy in pancreatic cancer. Co-author DOI 10.1039/c9nr04976b↗

Closest collaborators

The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kaihong Huang · 12 shared papers, 2020–2025 · strength 2.00
  2. Yaqing Li · 9 shared papers, 2020–2025 · strength 1.54
  3. Guoda Lian · 9 shared papers, 2020–2025 · strength 1.46
  4. Shurui Zhou · 6 shared papers, 2022–2024 · strength 1.06
  5. Shangxiang Chen · 6 shared papers, 2020–2025 · strength 0.90
  6. Shaojie Chen · 5 shared papers, 2022–2024 · strength 0.88
  7. Yue Zhao · 4 shared papers, 2024 · strength 0.79
  8. Ziyi Zhong · 4 shared papers, 2024 · strength 0.79
  9. Yinting Chen · 5 shared papers, 2020–2025 · strength 0.74
  10. Shaojie Chen · 4 shared papers, 2020–2025 · strength 0.68
  11. Kege Yang · 3 shared papers, 2024 · strength 0.59
  12. Hanming Yao · 3 shared papers, 2023–2024 · strength 0.54
  13. Yuzhou Huang · 3 shared papers, 2022–2024 · strength 0.51
  14. Jiajia Li · 2 shared papers, 2024 · strength 0.40
  15. Yunlong Li · 2 shared papers, 2024 · strength 0.40
  16. Linjuan Zeng · 2 shared papers, 2020–2025 · strength 0.37
  17. Jiajia Li · 2 shared papers, 2023–2024 · strength 0.35
  18. Fengjiao Li · 2 shared papers, 2022–2023 · strength 0.29
  19. Zhenfeng Tian · 2 shared papers, 2021–2022 · strength 0.28
  20. Jiajia Li · 1 shared paper, 2025 · strength 0.26
  21. Ying Tan · 2 shared papers, 2020–2021 · strength 0.23
  22. Yuzhou Huang · 1 shared paper, 2024 · strength 0.20
  23. Yanji Luo · 1 shared paper, 2023 · strength 0.18
  24. Ming Gao · 1 shared paper, 2023 · strength 0.18
  25. Yue Zhao · 1 shared paper, 2023 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.